General Information of Drug (ID: DMJVZ9O)

Drug Name
Cefdaloxime pentexil tosilate
Synonyms
HR-916B; HRT-916K; Cefdaloxime Pentexil Tosilate; HR-916J (1'R,6R, 7R);HR-916K (1'S,6R,7R); (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-(pivaloyloxy)ethyl ester 7(2)-(Z)-oxime tosylate; (6R,7R)-7-[2-(2-Aminothiazol-4-yl)-2(Z)-(hydroxyimino)acetamido]-3-(methoxymethyl)-3-cephem-4-carboxylic acid 1-(2,2-dimethylpropanoyloxy)ethyl ester tosylate
Indication
Disease Entry ICD 11 Status REF
Bacterial infection 1A00-1C4Z Discontinued in Phase 1 [1]
Cross-matching ID
PubChem CID
85046921
TTD ID
D04MDJ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Penicillin binding protein (Bact PBP) TTJP4SM NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003956)
2 Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin. Rev Esp Quimioter. 2006 Mar;19(1):39-44.